The last time I wrote about Centessa Pharmaceuticals plc (NASDAQ:CNTA), it was in a Seeking Alpha article ... phase 1 study ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback